Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 305-308

  Koga, Kaori ^a   Osuga, Yutaka ^a   Tajima, Toshiki ^a   Hirota, Yasushi ^a   Igarashi, Toshio ^b   Fujii, Tomoyuki ^a   Yano, Tetsu ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Hydatidiform mole; placenta; placental growth factot (PlGF); preeclampsia; pregnancy; soluble fms like tyrosine kinase 1 (sFlt1); vascular endothelical growth factor (VEGF)

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GESTATIONAL AGE; HUMAN; HYDATIDIFORM MOLE; MATERNAL AGE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; UTERUS SURGERY;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYDATIDIFORM MOLE; PREGNANCY; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 77952548868     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.015     Document Type: Article

References (12)

1. Kohorn E.I. Molar pregnancy: presentation and diagnosis. Clin Obstet Gynecol 27 (1984) 181-191
2. Soto-Wright V., Bernstein M., Goldstein D.P., and Berkowitz R.S. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 86 (1995) 775-779
3. Prasannan-Nair C., Reynolds S.F., and Budden G. Partial molar pregnancy with severe pre-eclampsia at 19 weeks' gestation. J Obstet Gynaecol 26 (2006) 817
4. Matsui H., Sekiya S., Hando T., Wake N., and Tomoda Y. Hydatidiform mole coexistent with a twin live fetus: a national collaborative study in Japan. Hum Reprod 15 (2000) 608-611
5. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26 (2001) 25-35
6. Koga K., Osuga Y., Yoshino O., Hirota Y., Ruimeng X., Hirata T., et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 88 (2003) 2348-2351
7. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
8. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
9. Okamoto T., Niu R., Mizutani S., and Yamada S. Levels of placenta growth factor in gestational trophoblastic diseases. Am J Obstet Gynecol 188 (2003) 135-140
10. Stepan H., and Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med 354 (2006) 1857-1858
11. Rana S., Venkatesha S., DePaepe M., Chien E.K., Paglia M., and Karumanchi S.A. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol 109 (2007) 549-552
12. Bdolah Y., Lam C., Rajakumar A., Shivalingappa V., Mutter W., Sachs B.P., et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?. Am J Obstet Gynecol (2008)